A Double-Blind Comparative Study of Opipramol and Amitriptyline in Neurotic and Endogenous Depressions

Author:

Rajotte Paul1,Bordeleau Jean-Marc2,Tétreault Léon3,Doucet Pierre4,Rajotte Elisabeth5

Affiliation:

1. Institut de Recherches Psychiatriques de Joliette, Saint Charles Hospital, Joliette, Quebec.

2. Institut Albert-Prévost. Department of Psychiatry, University of Montreal.

3. Department of Pharmacology, University of Montreal.

4. Institut Albert-Prévost.

5. Saint Charles Hospital, Joliette.

Abstract

A comparative double-blind study of two antidepressant drugs, opipramol and amitriptyline, had been undertaken in neurotic and endogenous depressions. It was to be carried out simultaneously in a well-staffed university clinic and in an understaffed mental hospital. The depression rating scale used was the one constructed by Wechsler et al. Criteria to differentiate both entities were those described by Kiloh and Garside. It was hoped; 1) to compare the efficacy of both drugs; 2) to compare differences in milieu in regard to the two types of depression and the drugs used; 3) to test the hypothesis, by means of comparing scores on the DRS, that there exists a difference between neurotic and endogenous depressions. The trial could not be completed because it was very difficult to find neurotic depressions at the state hospital and endogenous depressions at the university clinic. Although the results could not be compared in terms of both institutions and no conclusion could be drawn as to the efficacy of either drugs in neurotic depressions because of too small a sample, it was nevertheless shown that amitriptyline was significantly superior to opipramol in endogenous depressions. Some methodological flaws of the present study were pointed out, namely, the lack of placebo in the neurotic group, the drawback of a flexible posology and the short observation period (4 weeks). Explanations were propounded to explicate the sampling difference between the two psychiatric institutions.

Publisher

SAGE Publications

Subject

General Medicine

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Update Opipramol;Fortschritte der Neurologie · Psychiatrie;2017-03-20

2. Amitriptylinev.the rest: still the leading antidepressant after 40 years of randomised controlled trials;British Journal of Psychiatry;2001-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3